{
  "docId": "019dd923-622c-750b-8b9a-3bcd52c6e583",
  "docSlug": "f06b0b5d2079",
  "documentTitle": "Soleno Therapeutics (SLNO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-08-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 279,
  "pageCount": 415,
  "prevPage": 278,
  "nextPage": 280,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 1,
  "notes": "The slide uses highlighted quotes from a former senior medical affairs employee to undermine the commercial viability of Vykat.",
  "elementsJson": [
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-3bcd52c6e583/279",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-3bcd52c6e583#slide-279",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "The ex-employee stated that GLP-1’s have already made Vykat irrelevant and erased its commercial opportunity, indicating that half of PWS physicians are already trying to use GLP-1’s.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2ae-7189355bd8e1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.86,
        "x": 0.07,
        "y": 0.51
      },
      "kind": "paragraph",
      "text": "Patients and physicians care more about weight loss than hyperphagia: emerging focus on GLP-1's",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7bee9382-61af-49b4-9cdd-f843d42f9211",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.86,
        "x": 0.07,
        "y": 0.65
      },
      "kind": "paragraph",
      "text": "Potentially half of PWS physicians trying to use GLP's",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "801fb5db-6744-47b3-b17e-f761d1986886",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.86,
        "x": 0.07,
        "y": 0.82
      },
      "kind": "paragraph",
      "text": "Physicians will try cheaper options first like GLP's and Vykat will be \"a last resort type scenario\"",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ecd61a81-9eb3-4aeb-bf5f-6fa4bd10c22e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.86,
        "x": 0.07,
        "y": 0.87
      },
      "kind": "quote",
      "text": "I hesitate to say anything because I think drug prices are way out of control...I think the problem is that a lot of physicians are going to weigh that against the cost of the GLP-1's...I think they may try other things like GLP-1's and some other drugs first, that this may end up being sort of like a last resort type scenario.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "131ae361-a46a-46ad-af87-53e952a317eb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.86,
        "x": 0.07,
        "y": 0.54
      },
      "kind": "quote",
      "text": "But here's the problem. Here's the problem. A lot of physicians and families are so focused on weight loss for good health reasons that when they look at the study and don't see the weight loss, it causes them pause because of the expense with this...So, once the GLP-1 became available, a lot of physicians targeted that way to help with weight loss. And we're seeing a lot of positive results with that.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c316dd8-88a0-405f-8571-64cb2286aa9b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.86,
        "x": 0.07,
        "y": 0.71
      },
      "kind": "quote",
      "text": "I think probably 50% of them, if they could get it approved, were starting to put these patients on GLP-1, said yes, they were seeing weight loss, but I don't think they were seeing behavior changes.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e9bd3cc4-d70d-43ff-976b-1c40d3d70f4c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"But here's the problem. Here's the problem. A lot of physicians and families are so focused on weight loss for good health reasons that when they look at the study and don't see the weight loss, it causes them pause because of the expense with this...So, once the GLP-1 became available, a lot of physicians targeted that way to help with weight loss. And we're seeing a lot of positive results with that.\" — Formerly in a senior medical affairs role at Soleno",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64ce-7561-b2ae-750557185598",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.3,
        "x": 0.07,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d01ebe3f-0814-4827-8c40-65b0406bc0a0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "title",
      "text": "The ex-employee stated that GLP-1’s have already made Vykat irrelevant and erased its commercial opportunity, indicating that half of PWS physicians are already trying to use GLP-1’s; that patients and doctors care more about weight loss than hyperphagia",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "479f29e3-9095-45b8-bae9-8a28e4385a7e",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "authority-citation",
      "slug": null,
      "matchId": "b8911c0e-ee79-49c3-9333-f1b52124cd5d",
      "evidence": "Uses expert testimony from a former employee to validate the thesis.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}